Carregant...
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Remarkable progress has been achieved for prophylactic and therapeutic interventions against human immunodeficiency virus type I (HIV-1) through antiretroviral therapy. However, vaccine development has remained challenging. Recent discoveries in broadly neutralizing monoclonal antibodies (bNAbs) has...
Guardat en:
| Publicat a: | Front Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Higher Education Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8320319/ https://ncbi.nlm.nih.gov/pubmed/31858368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11684-019-0721-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|